DUBLIN–(BUSINESS WIRE)–The «Gene Expression Analysis: Global Strategic Business Report» has been added to ResearchAndMarkets.com’s offering.
Global Gene Expression Analysis Market to Reach $6.6 Billion by 2027
In the changed post COVID-19 business landscape, the global market for Gene Expression Analysis estimated at US$3.6 Billion in the year 2020, is projected to reach a revised size of US$6.6 Billion by 2027, growing at a CAGR of 9.2% over the analysis period 2020-2027. Instruments, one of the segments analyzed in the report, is projected to record a 8.7% CAGR and reach US$2.9 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Consumables segment is readjusted to a revised 9.9% CAGR for the next 7-year period.
The U.S. Market is Estimated at $974.5 Million, While China is Forecast to Grow at 13.7% CAGR
The Gene Expression Analysis market in the U.S. is estimated at US$974.5 Million in the year 2020. China, the world’s second largest economy, is forecast to reach a projected market size of US$1.5 Billion by the year 2027 trailing a CAGR of 13.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.3% and 8.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 6.2% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$914.9 Million by the year 2027.
Services Segment to Record 9% CAGR
In the global Services segment, USA, Canada, Japan, China and Europe will drive the 9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$538.5 Million in the year 2020 will reach a projected size of US$942.8 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Latin America will expand at a 10.5% CAGR through the analysis period.
Select Competitors (Total 42 Featured) –
- Agilent Technologies
- Bgi
- Bio-Rad Laboratories, Inc.
- ELITechGroup
- Eurofins Scientific
- F. Hoffmann-La Roche
- Ge Healthcare
- Illumina,Inc.
- Novogene Corporation
- Oxford Gene Technology
- Pacific Biosciences of California, Inc.
- Perkinelmer, Inc.
- Qiagen N.V.
- Takara Bio, Inc.
- Thermo Fisher Scientific, Inc.
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Impact of Covid-19 and a Looming Global Recession
- Gene Expression Analysis – Global Key Competitors Percentage Market Share in 2022 (E)
- Competitive Market Presence – Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
IV. COMPETITION
Companies Mentioned
- Agilent Technologies
- Bgi
- Bio-Rad Laboratories, Inc.
- ELITechGroup
- Eurofins Scientific
- F. Hoffmann-La Roche
- Ge Healthcare
- Illumina,Inc.
- Novogene Corporation
- Oxford Gene Technology
- Pacific Biosciences of California, Inc.
- Perkinelmer, Inc.
- Qiagen N.V.
- Takara Bio, Inc.
- Thermo Fisher Scientific, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/oxr2xv.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
